Oct 08 2020

The Association Between Parkinson's Disease and Attention-Deficit Hyperactivity Disorder.

Hueng-Chuen Fan, Yu-Kang Chang, Jeng-Dau Tsai, Kuo-Liang Chiang, Jui-Hu Shih
& 3 others
Author Affiliations
Cell transplantation(United States)

While Parkinson's disease (PD) and attention-deficit hyperactivity disorder (ADHD) are two distinct conditions, it has been hypothesized that they share several overlapping anatomical and neurochemical changes. In order to investigate that hypothesis, this study used claims data from Taiwan's Longitudinal Health Insurance Database 2000 to provide the significant nationwide population-based evidence of an increased risk of PD among ADHD patients, and the connection between the two conditions was not the result of other comorbidities. Moreover, this study showed that the patients with PD were 2.8 times more likely to have a prior ADHD diagnosis compared with those without a prior history of ADHD. Furthermore, an animal model of ADHD was generated by neonatally injecting rats with 6-hydroxydopamine (6-OHDA). These rats were subjected to behavior tests and the 99mTc-TRODAT-1 brain imaging at the juvenile stage. Compared to control group rats, the 6-OHDA rats showed a significantly reduced specific uptake ratio in the striatum, indicating an underlying PD-linked pathology in the brains of these ADHD phenotype-expressing rats. Overall, these results support that ADHD shares a number of anatomical and neurochemical changes with PD. As such, improved knowledge of the neurochemical mechanisms underlying ADHD could result in improved treatments for various debilitating neurological disorders, including PD.

Keywords: 6-hydroxydopamine, Longitudinal Health Insurance Database 2000, Parkinson’s disease, attention-deficit hyperactivity disorder
Journal Article
Cell Transplant. ;29:963689720947416

Suggested Articles

Oct 19 2020
The Impact of Sex and Gender on the Multidisciplinary Management of Care for Persons With Parkinson's Disease.
Frontiers in neurology
Oct 19 2020
Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Oct 13 2020
Hoping for the best, planning for the worst: Palliative care approach to Parkinson disease during the COVID-19 pandemic.
Parkinsonism & related disorders